Try our beta test site

Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:
NCT00151203
First received: September 6, 2005
Last updated: February 13, 2017
Last verified: February 2017